The EU-funded project REBECCA taps into the potential of Real-World Data to support clinical research and to improve existing clinical workflows.
It will combine clinical data with data obtained from multiple wearable, online behaviour and registry data to study the complex array of chronic comorbidities developed during breast cancer recovery. The data will be deployed within 7 clinical studies in 3 countries, involving over 650 individuals, and it will help shape future guidelines and practices for post-cancer treatment.
How will you benefit from REBECCA?
Sign up to our newsletter
Sign up for our mailing list to receive occasional emails as we publish key project materials and commission new strands of work.
More impact of clinical research on breast cancer patients
Clinical and technological universities, industry leaders, public health experts, and patient associations will work together to shape guidelines and practices for post-cancer treatment. Best practices from the REBECCA studies will be disseminated to researchers, public health and regulatory bodies throughout Europe to facilitate wider adoption of RWD in clinical research.
REBECCA will provide an infrastructure for continued progress on the use of RWD beyond the project, facilitating the mass adoption of RWD as a valuable clinical research and patient management tool.
Find Out More
How we will do it
Our work packages are evolving, but include consideration and development of:
Find out about the latest REBECCA related news.
Revolutionising Cancer Care: the REBECCA App Aims to Improve Patients’ Quality of Life and Communication with Doctors
The Stavanger University Hospital (SUH) together with the Cancer Society in Rogaland County, Norway, organised a meeting with breast and prostate cancer patients to promote the REBECCA system and explain how personalised treatment plans based on real-world data collection can address the complex …
Stavanger HF successfully recruited participants to two of the REBECCA studies using hospital intranet.
Breast cancer is a life-changing diagnosis that affects many women across the world. The REBECCA project aims at improving the quality of life for breast cancer patients by conducting multiple studies and combining data from different sources. The Stavanger University Hospital’s intranet, Pulsen,…
Towards better stakeholder engagement: looking back to the World Cancer Day 2023 results
This year’s World Cancer Day campaign with a catchy slogan “Close The Care Gap” among other things, provided an in-depth look at the socioeconomic factors, such as cultural contexts, gender norms, income and education levels, as well as the prejudices, discrimination and assumptions based on age,…
The project brings together 12 partners from 7 European countries. Clinical and technological universities, industry leaders, public health experts, and patient associations will work together to shape guidelines and practices for post-cancer treatment.
“Cancer Survivorship – AI for Well-being”
Rebecca is a member of the “Cancer Survivorship – AI for Well-being” (CS_AIW) consortium, a collection of EU-funded projects that were launched in late 2020 under the banner of “Breaking Down Silos”. These projects share two fundamental principles. Firstly, they all aim to tackle critical issues surrounding mental health, well-being, depression, and patient support. Secondly, they embrace a participatory research philosophy, promoting a cohesive and collaborative approach to their endeavours.
Find Out More